Brief: Vicore Pharma Holding Q1 Operating Loss Widens To SEK 4.2 Million
08/05/2018 08:09
May 8 (Reuters) - VICORE PHARMA HOLDING AB VICOR.ST :
* Q1 OPERATING LOSS SEK 4.2 MILLION VERSUS LOSS SEK 2.5
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr15Wc6y
Further company coverage: VICOR.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2